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Tissue morphogenesis is crucial for the development of metazoans. C. 
elegans, is a model system for studying tissue morphogenesis, as there are 
many genetic tools available, and embryos are amenable to microscopy. We 
study ventral enclosure, which is the process where ventral epidermal cells 
migrate to enclose the C. elegans embryo in a single layer of epidermal cells. 
This process is initiated by the migration and adhesion of two pairs of anterior 
leading cells, followed by the migration and adhesion of eight pairs of posterior 
pocket cells. The migration of the leading cells is mediated by F-actin rich 
filopodia-like protrusions, which are under the control of the Rac – Wave/Scar – 
Arp2/3 pathway. Cables of F-actin become enriched around the margins of the 
pocket cells to form a ring, and early studies showed that this ring is under 
tension. Based on this data, actomyosin contractility was predicted to mediate 
the closure of this ring during ventral enclosure. However, nonmuscle myosin has 
not been studied in ventral enclosure, where it could regulate ring closure in 
addition to regulating cell shape changes and/or adhesion. For example, proteins 
that form adhesion junction complexes are also required for ventral enclosure, as 
they maintain contacts between cells so they can migrate as a unit and form new 
junctions with contralateral neighbors.  
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Our studies support a role for myosin contractility in ventral enclosure. 
RhoA regulates nonmuscle myosin contractility for cytokinesis in the early 
embryo and for elongation of the lateral epidermal cells in late embryogenesis. 
ECT-2 is the GEF that activates RhoA during cytokinesis, and a different GEF, 
RHGF-2, activates RhoA during late embryogenesis. A hypomorphic, maternal ts 
allele of ect-2, ax751, is required for polarity in the early embryo, but displays few 
cytokinesis defects, especially at non-permissive temperatures. Using this allele, 
we found that ect-2 is required for the migration of neuroblasts during earlier 
embryonic stages, and ventral epidermal cells during ventral enclosure. Genetic 
crosses suggest that ect-2 functions in parallel to the Rac pathway and may be 
part of the Rho pathway to regulate actomyosin contractility, supporting a role for 
myosin in ventral enclosure. Imaging and quantification of embryos expressing 
GFP-tagged myosin showed that myosin forms into a supracellular structure 
around the margins of the ventral pocket cells, reminiscent of the actin ring 
described previously. We found that ect-2 is required for the enrichment and 
organization of myosin, supporting a requirement for ect-2 in regulating myosin 
contractility. Interestingly, ect-2 may also function in the cadherin/catenin 
pathway that forms adhesion junctions, suggesting ect-2 could also regulate the 
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 Organs form during embryonic development by the morphogenesis of 
cells that undergo coordinated shape changes and migration. Many homeostatic 
events, such as wound healing, also require cells to coordinate shape changes 
and migration. Furthermore, similar types of cellular events drive metastasis: the 
spreading of cancer cells to other parts of the body (Bompard et al., 2005). 
Therefore, understanding how cells change shape and migrate, particularly in a 
coordinated manner, can shed light on how morphogenetic events are regulated 
for various processes including development, wound healing, and cancer (Wong 
and Schwarzbauer, 2012). Invertebrate models such as Caenorhabditis elegans 
are ideal to use for studying tissue morphogenesis. Due to its rapid life-cycle (3.5 
day at 20ºC), transparency, genetics, and amenability to transgenics and RNAi, 
C. elegans are well-suited for light microscopy, and visualization of tissue 
formation during development (Figure 1) (Glavis-Bloom et al., 2012). Maternally-
expressed proteins are loaded into oocytes within the germline and regulate early 
embryogenesis. Depending on the gene, zygotic expression may start in mid-
embryogenesis, and transition to full zygotic requirement by late embryogenesis 
(Newman-Smith and Rothman, 1998). Epidermal morphogenesis is initiated 
during mid-embryogenesis by the intercalation of cells on the dorsal side of the 
embryo, and is followed by the migration of ventral epidermal cells to form a 
tissue around the embryo (Williams-Masson et al., 1997). The simple 
organization of this tissue, availability of markers, and the high degree of 





Figure 1. C. elegans life cycle. The life cycle of C. elegans at 22
0
C is shown from the first cell 
division, through embryonic development, larval development and to adulthood. The stages of 
embryogenesis that are shown are the first cell division (2-cell stage), gastrulation, and mid-late 
events including ventral enclosure and elongation. Embryos in mid-embryogenesis are circled, 
which is when many genes transition from maternal to zygotic expression. When food is low, L1 
larva can exit the life cycle and become a dauer form that is highly resistant to changes in 
temperature, dehydration and limited food supplies. This figure is adapted from artwork by Altun 










ideal for studying how the cytoskeleton is regulated to mediate changes in cell 
shape and migration for morphogenetic events.   
1.1 C. elegans embryogenesis  
1.1.1 Gatrulation: from cell division to tissue specific  
C. elegans epidermal morphogenesis occurs through several distinct 
steps. All epidermal cells are born as six rows of cells on the dorsal surface of 
the embryo. In the first step of tissue formation, dorsal epidermal cells intercalate 
on the dorsal surface of the embryo (dorsal intercalation), and in the second step, 
ventral epidermal cells change shape and migrate toward the ventral midline 
where they adhere (ventral enclosure). Subsequently, the epidermal cells 
constrict to drive the overall shape change of the worm (elongation). However, 
prior to epidermal morphogenesis, there are other migratory events that occur in 
the early embryo to produce the future tissues of the organism. For example, 
when embryos reach the 26-cell stage, gastrulation begins by the migration and 
ingression of cells to form 3 germ layers; endoderm, ectoderm, and mesoderm. 
Precursor cells for internal organs (e.g. intestine, germline, and pharynx) and 
body wall muscle ingress from the ventral surface of the embryo, leaving a 
depression, known as the ventral cleft. The ventral cleft is surrounded by 
neuroblasts, which subsequently migrate to fill in the space by a process known 
as ventral cleft closure (Pohl et al., 2012). The machinery that regulates cell 
migration and shape changes for gastrulation and ventral cleft closure likely uses 
some of the same components that regulate epithelial morphogenesis in later 
development (Chisholm and Hardin, 2005). In support of this, mutations in genes 
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required for the migration of ventral epidermal cells during ventral enclosure are 
also required for the migration of neuroblasts during ventral cleft closure (George 
et al., 1998; Chin-Sang et al., 1999; Bernadskaya et al., 2012). Furthermore, 
actomyosin contractility (see section 1.4) is essential for the constriction of 
epidermal cells during elongation, and also is required for the ingression of cells 
during gastrulation (Piekny et al., 2000; Lee and Goldstein, 2003). 
1.1.2 C. elegans embryogenesis: ventral enclosure and elongation 
 Ventral enclosure begins with the migration of two pairs of anterior-
positioned ventral epidermal cells (leading cells) toward the ventral midline, 
where they meet and form new junctions with their contralateral neighbours 
(Figure 2) (Williams-Masson et al., 1997; Chisholm and Hardin, 2005). Migration 
of the leading cells is crucial for ventral enclosure; inactivation of these cells by 
laser ablation can inhibit ventral enclosure and cause the embryo to rupture 
during elongation (Williams-Masson et al., 1997). Their migration requires the 
formation of filopodia, and relies on pathways that regulate the formation of short, 
branched F-actin (Patel et al., 2008). Posterior-positioned ventral epidermal cells 
(ventral pocket cells), subsequently migrate and adhere with their contralateral 
neighbours at the ventral midline (Chin-Sang and Chisholm, 2000; Chisholm and 
Hardin, 2005). These cells do not form filopodia and instead have F-actin cables 
at their margins, which appear to form a ring. This pattern lead to the prediction 
that they close via a purse-string like mechanism, which requires actomyosin 




Figure 2. C.elegans ventral enclosure. During mid-embryogenesis, (A-D) epidermal cells (pink) 
initially born in the dorsal side extend, migrate on top of neuroblasts (grey) to adhere at the 
ventral midline. Starting by migration and adhesion of leading cells, then follow by the closure of 
ventral pocket cells at the ventral midline. (E-H) Show correspondent DIC image of VE process, 
and (I-L) show embryo expressing fluorescent marker in epidermal cells undergoing VE. Figures 








completed, the embryo is wrapped in a single layer of epidermis and undergoes 
elongation. 
 Elongation is driven by the constriction of lateral epidermal cells (seam 
cells), which elongates the embryo along the anterior-posterior axis, and 
transforms the embryo into the typical long-thin worm shape (Priess and Hirsh, 
1986; Chisholm and Hardin, 2005). This process is driven by a combination of 
actomyosin contractility within the seam cells, which transforms their shape from 
a cube to a cylinder, and mechanotransduction from the underlying muscle cells 
(Piekny et al., 2003; Zhang et al., 2011). Mutations in genes that affect 
contractility, or disrupt the underlying muscle cause elongation phenotypes 
(Williams and Waterston, 1994; Shelton et al., 1999; Piekny et al., 2000). 
1.2 Ventral enclosure regulation  
1.2.1 Cell migration  
The migration of ventral epidermal cells is essential for ventral enclosure, 
and is driven by the formation of long, thin actin-enriched protrusions at the 
leading edge of the cells that extend toward the ventral midline. When epidermal 
cells meet and adhere with their contralateral neighbors, filamentous actin (F-
actin)-rich protrusions overlap and form thick bands of F-actin at the newly 
forming adhesion junctions (Williams-Masson et al., 1997). Genes required to 
form the filopodia/lamelipodia protrusions encode GTPase Rac/CED-10, the 
Wave/Scar complex, and Arp2/3. In this pathway, Rac/CED-10 activates the 
Wave/Scar complex (comprised of GEX-2, GEX3, ABI-1 and WVE-1), which 
serves as a nucleation-promoting-factor to activate the Arp2/3 complex for the 
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polymerization of short, branched F-actin (Figure 3) (Soto et al., 2002; Patel et 
al., 2008; Shakir et al., 2008). Arp2/3 complex can also be activated by members 
in the WASP protein family, which are homology proteins with Wave/Scar, share 
conservative domains respond for binding and activating Arp2/3. Unlike 
Wave/Scar, WASP proteins are auto-inhibited and activated upon Cdc-42 
activation (Pollitt and Insall, 2009). Mutations in any of these genes impede cell 
migration, causing the ventral epidermal cells to remain on the dorsal surface of 
the embryo and the internal contents of the embryo to extrude, causing the ‘Gut 
on the exterior’ (Gex) phenotype (Soto et al., 2002; Sawa et al., 2003; Patel et 
al., 2008). 
In other cell types, nonmuscle contractility provides forces in the rear of 
the cell for migration, however it is not known if myosin is required for ventral 
epidermal cell migration. As ventral epidermal cells migrate, they lengthen and 
undergo apical constrictions, and myosin could be required to mediate these 
changes. Furthermore, as described earlier, the closure of the pocket cells likely 
occurs by contractility to close them by a purse-string mechanism. However, it 
has been challenging to study a role for myosin in ventral enclosure due to the 
lack of ts (temperature sensitive) alleles in the pathway that regulates myosin 
contractility. Many of these components are maternally required for cytokinesis in 
the early embryo, and zygotically required for elongation during late 
embryogenesis. Therefore, ts alleles are essential for studying requirements in 





Figure 3. The Rac/Cdc-42 pathway for cell migration. This schematic shows the pathway that 
is regulated by the small GTPases, Rac and Cdc-42, for cell migration. Upon their activation, Rac 
or Cdc42 will regulate downstream effectors including WASP or WAVE/Scar to activate Arp2/3 to 
form branched F-actin. These actin filaments are important for forming lamellipodia or filopodia at 














1.2.2 Adherens junctions  
Tissue morphogenesis requires cells to change shape and migrate in a 
coordinated manner. Adhesion junctions form between neighbouring epithelial 
cells, which transmit forces across multiple cells and allow them to move as a 
unit. C. elegans epithelial cells contain two adhesion complexes: the cadherin-
catenin complex (CCC) and the DLG-1/AJM-1 complex (DAC) (Figure 4) 
(Labouesse, 2006). The CCC is the most apical complex in the junction, and  
contains multiple components. E-cadherin (HMR-1) is a transmembrane protein 
with an extracellular domain that homotypically binds to other E-cadherins, and 
an intracellular domain that interacts with other proteins. In this way, E-cadherin 
functions to directly link neighbouring cells (Costa et al., 1998). In addition, α-
catenin (HMP-1) binds to F-actin, and β-catenin (HMP-2) crosslinks α-catenin to 
E-cadherin (Costa et al., 1998; Labouesse, 2006). The DLG-1/AJM-1 complex is 
more sub-apical in comparison to the CCC, and includes DLG-1 (homologue of 
Discs large in Drosophila), and AJM-1, a coiled-coil protein (Labouesse, 2006). 
These junctions allow forces to be transmitted across cells, which is important for 
tissue formation and to maintain tissue integrity (Loveless and Hardin, 2012). 
Genes that regulate cell adhesion and encode components of the CCC are 
required for ventral enclosure. Ventral epidermal cells still migrate toward the 
midline in CCC mutant embryos, but cells fail to form stable contacts with 
contralateral neighbours and display rupture phenotypes or variable abnormal 





Figure 4. C. elegans adherens junctions. This cartoon shows the adherens junction in a C. 
elegans epithelial cell. These junctions are comprised of the cadherin-catenin complex (CCC) and 
the DLG-1/AJM-1 complex (DAC). The legend on the right shows the different components in the 
two complexes, which work together to maintain cell-cell adhesion, and allows forces to be 
transmitted across cells through the intracellular actin cytoskeleton. Cells lacking both CCC and 
DAC components have rounded epithelial cells that cannot adhere. This figure is adapted from 










nonmuscle myosin is required for junction formation and stability, but it is not 
known if myosin contributes to junctions in C. elegans embryos (Vicente-
Manzanares et al., 2009).   
1.3 Neuroblasts and their role in epidermal morphogenesis  
As described earlier, neuroblasts migrate to close the ventral cleft that was 
left after gastrulation. Their movement produces a surface of neuroblasts on the 
ventral side of the embryo, which serves as a substrate for the migration of 
ventral epidermal cells during ventral enclosure (Chisholm and Hardin, 2005). 
The main pathways that regulate neuroblast migration involve the Eph receptor 
(VAB-1)/Ephrin, PTP-3/LAR RPTP (Leukocyte Common Antigen Related 
Receptor Protein phosphatase) and semaphorin-2A/MAB-20, known for their 
roles in axon guidance (Chin-Sang et al., 1999; Chin-Sang et al., 2002; 
Harrington et al., 2002). Defects in these genes prevent neuroblasts from sorting 
to their appropriate regions, and result in an enlarged or persistent ventral cleft 
and abnormal ventral enclosure. The receptors for these pathways (e.g. ephrin 
and semaphorin) are also expressed in the epidermal cells, and the cues 
secreted from the neuroblasts signal these receptors to help guide the migration 
of ventral epidermal cells toward the ventral midline (Bernadskaya et al., 2012). 
There are still a lot of open questions about the role of neuroblasts in 
mediating ventral epidermal cell migration, particularly since the receptors for 
secretory cues are found in both the neuroblasts and in the overlying epidermal 
cells. Tissue-specific rescue experiments suggest that ventral epidermal cell 
migration only requires the expression of receptors in the epidermal cells 
12 
 
(Ikegami et al., 2012). However, the source of the cue is not well understood, and 
there are several pathways involved in ventral enclosure, and their relative 
contributions are not well understood. Furthermore, neuroblast division and 
position is essential for ventral enclosure, but it is not clear if this is because the 
cue no longer forms the appropriate gradient, or if there are mechanical functions 
provided by the neuroblasts (Fotopoulos et al., 2013). For example, one subset 
of ventral neuroblasts serve as a ‘bridge’ for the migration of overlying ventral 
epidermal cells, and changes in their position or shape lead to the misalignment 
and failure of ventral pocket closure during ventral enclosure (Ikegami et al., 
2012).   
1.4 Molecular regulation of actomyosin contractility 
1.4.1 F-actin  
  While formins are not known to be required for ventral enclosure, the 
formation of F-actin bundles at the apical ends of epidermal cells during closure 
of the ventral pocket supports their requirement. Actomyosin contractility uses F-
actin that is long and unbranched, which is polymerized by formins. Formins 
contain several domains that are required for their regulation and function. At the 
core of the protein are the FH1 and FH2 domains: the FH1 domain binds to 
profilin-bound actin monomers, while the FH2 domains homodimerize to form a 
donut structure (Xu et al., 2004). This donut associates with the barbed end of 
the growing F-actin filament, and the FH1 domains extend out, bind to profilin-
actin monomers and assemble them into the filament (Pruyne et al., 2002). 
Formins also contain a DID and a DAD domain, which interact and inhibit formin 
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activity by preventing dimerization of the FH2 domains. Active RhoGTPase binds 
to a domain that overlaps with the DID to relieve this autoinhibition (Goode and 
Eck, 2007). Formin-polymerized F-actin is crucial for actomyosin contractile 
events such as cytokinesis, cell shape changes during epithelial morphogenesis, 
and formation of stress fibers during migration (Pollard, 2007). 
1.4.2 Myosin  
While myosin is not known to be required for ventral enclosure, one of the 
persisting models used to describe closure of the ventral pocket relies on 
actomyosin contractility. This model was derived from the observation that a ring 
of bundled F-actin forms around the pocket cells, which appears to constrict as 
they close (Williams-Masson et al., 1997). Purse-string mechanisms have been 
described for other cellular events including wound healing, where an actomyosin 
cable forms along the wound edge and constricts to close the wound, and 
cytokinesis, where an actomyosin ring pinches in the cell to form two daughter 
cells (Bement et al., 1993; Piekny et al., 2005). Nonmuscle myosin is also 
required for apical constriction, which changes cell shape for morphogenetic 
events such as dorsal closure in Drosophila and gastrulation in C. elegans 
(Franke et al., 2005; Roh-Johnson et al., 2012). 
In nonmuscle cells, nonmuscle myosin II is the main myosin that cross-
links actin filaments and produces contractile forces. Myosin is a hexamer with 
two pairs of heavy chains (NMY-1 or NMY-2 in C. elegans), two pairs of essential 
light chains (MLC-3 in C. elegans) and two pairs of regulatory light chains (RLC; 
MLC-4 in C. elegans). Myosin activity is regulated by phosphorylation of the RLC, 
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which promotes dimerization of the heavy chains and stimulates ATPase activity 
in the motor domain (Vicente-Manzanares et al., 2009). Several kinases 
phosphorylate RLC, including Rho-associated kinase (ROK) and citron kinase, 
both of which are Rho effectors that are regulated by binding to active RhoA 
(Matsumura, 2005). The activity of myosin is also negatively regulated by myosin 
phosphatase, which removes the phosphate from RLC (Matsumura and 
Hartshorne, 2008). Interestingly, ROK can also phosphorylate and inhibit the 
regulatory subunit of myosin phosphatase to promote myosin activity (Vicente-
Manzanares et al., 2009).  
 In C. elegans, non-muscle myosin and its regulators (e.g. mlc-4, let-502 
and mel-11) are required for multiple actomyosin contractile events throughout 
embryogenesis, including cytokinesis, gastrulation and elongation (Shelton et al., 
1999; Piekny et al., 2000; Piekny and Mains, 2002; Pohl et al., 2012). However, 
due to the limitations of existing alleles and effects of RNAi, which causes 
defects in early embryogenesis, studies have not yet investigated requirements 
for myosin contractility during ventral enclosure.          
1.4.3 The RhoGEF ECT-2 
In mammalian cells, Ect2 was initially identified as oncogene due to its ability 
to transform cells (Miki et al., 1993). Overexpression or un-regulated Ect2 can 
cause abnormal cell morphologies and tumor formation in mice (Takai et al., 
1995). Ect2 has two BRCT domains in its N-terminus, which form a phosphor-
binding motif, and autoregulates Ect2 activity. This domain mediates the 
formation of an inactive conformation of Ect2 that is relieved when Ect2 binds to 
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other proteins. The C-terminal half of Ect2 contains lipid binding motifs and a 
GEF domain, which catalyzes the exchange of GDP to GTP on RhoGTPases 
(Morita et al., 2005). One of Ect2’s best-described functions is for cytokinesis. It 
generates active RhoA, which binds to effectors such as formins for the 
polymerization of F-actin, as well as ROK and citron kinase to facilitate RLC 
phosphorylation for myosin activation. This leads to the formation and ingression 
of an actomyosin ring to pinch the cell into two daughter cells (Piekny et al., 
2005). In cancer cells, Ect2 is no longer sequestered to the nucleus in 
interphase, and is retained in the cytoplasm where it activates RhoGTPases for 
tumor cell growth, invasion and migration (Fields and Justilien, 2010). For 
example, in brain cancer cells (glioblastoma), Ect2 activates Cdc42 and Rac for 
their migration and invasion (Kwiatkowska et al., 2012).  
ECT-2 and other components of the RhoA pathway are conserved in C. 
elegans where they regulate cytokinesis in the early embryo (Figure 5) (Shelton 
et al., 1999; Piekny and Mains, 2002; Severson and Bowerman, 2002; Dechant 
and Glotzer, 2003). Therefore, it is difficult to study the requirement for myosin 
contractility in later stages of embryonic development. Using zygotic-specific 
alleles, these components were shown to be required during late embryogenesis, 
to mediate cell shape changes for elongation (Shelton et al., 1999; Piekny et al., 
2000; Piekny et al., 2003). However, ECT-2 does not function at this stage of 
development, and instead a different RhoGEF, RHGF-2, activates RhoA to 
regulate myosin contractility for elongation (Lin et al., 2012). C. elegans ect-2 has 




Figure 5. Actomyosin contractility pathway in the early embryo. This schematic shows the 
pathway that regulates actin polymerization and nonmuscle myosin contractility during early 
embryogenesis. ECT-2 is a Rho GEF that activates RHO-1, which binds to effectors for actin 
polymerization (formins and profilins) and nonmuscle myosin contractility (Rho-binding kinase). 
Myosin is comprised of the regulatory light chain (MLC-4) and heavy chain (NMY-2), and its 
activity is regulated by phosphorylation of MLC-4. Myosin phosphatase (the regulatory subunit is 









elegans embryos, ect-2 is also required for anterior-posterior polarity, and this 
function occurs via its regulation of RhoA (Zonies et al., 2010). Also, depletion of 
zygotic ect-2 causes adult sterility, which arises due to defects in the division and 
migration of epidermal P cells, a subset of vulva precursor cells (Morita et al., 
2005). 
 
1.5 Drosophila epidermal morphogenesis as a model for C. elegans 
In Drosophila, Pebble (Pbl) is the ortholog of C. elegans ECT-2, and is 
essential for cytokinesis and migration (Smallhorn et al., 2004). Pbl activates 
Rho1 at the cell cortex to orchestrate the formation and ingression of the 
actomyosin contractile ring for cytokinesis. During gastrulation, Pbl regulates 
myosin contractility for the apical constriction and internalization of precursor 
mesodermal cells. Interestingly, the apically-enriched actomyosin fibres are 
linked by junctions to form a supracellular meshwork, which provides forces that 
drive the internalization of mesoderm precursors (Martin et al., 2010). During 
gastrulation, a subset of epithelial cells undergoes epithelial-mesenchymal 
transitions (EMT), where their identity is transformed to a mesodermal fate (Lim 
and Thiery, 2012). The spreading of these mesodermal cells over the ectoderm 
is Pbl-dependent. This process is largely driven by F-actin rich protrusions, and is 
regulated by a Pbl-Rac pathway (van Impel et al., 2009). Interestingly, Rho1 and 
myosin contractility do not seem to be required for mesodermal spreading, 
although these pathways were determined by genetic suppression, and the 
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requirement for Rho1 and myosin in other processes may preclude studying their 
specific roles in migration. 
 One of the steps in Drosophila epithelial morphogenesis is when dorsal 
epithelial cells cover the dorsal surface of the embryo by a myosin-dependent 
process called dorsal closure. A second tissue, the amnioserosa (an extra-
embryonic structure), acts as a substrate to coordinate the movement of the 
overlying epidermal sheets to the dorsal midline (Jacinto et al., 2002). Dorsal 
closure requires cell shape changes, as well as the extension and migration of 
epidermal cells toward dorsal midline, and contractions from underlying 
amnioserosa (Kiehart et al., 2000). Importantly, a thick actomyosin cable forms 
around the edge of the migrating epithelial cells during dorsal closure, and may 
close epithelial sheets together by a purse-string mechanism, similar to wound 
healing (Martin and Lewis, 1992; Bement et al., 1993). Actin becomes more 
intense at the front part of the migrating epidermal cells, which change in 
appearance from ‘scalloped’ to a smooth arch, as cells progress (Kiehart et al., 
2000). Consistent with a requirement for actomyosin contractility in mediating 
dorsal closure, null myosin mutants fail dorsal closure, and have lower tension at 
the edge of the epidermal cells. Mutants for rho1 have reduced actomyosin 
cables, and display reduced tension at the front edge of the cells (Lu and 
Settleman, 1999; Jacinto et al., 2002). Pbl, the Drosophila ortholog of ECT-2, is 
also required for dorsal closure and regulates tension at the front of the migrating 
epidermal cells (Jankovics et al., 2011). In addition, Rho1 accumulates apically to 
regulate the formation and stability of adherens junctions during dorsal closure 
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(Magie et al., 2002). The underlying amnioserosa works as substrate for 
epidermal cells during dorsal closure, and cells in this tissue display extensive 
contractions and cell shape changes. Large-scale actomyosin structures 
assemble at the apical surface to mediate their constriction, which decreases the 
surface area of amnioserosa. This somehow coordinates the overlying epidermal 
cells during dorsal closure, and facilitates its disappearance (Kiehart et al., 2000).   
 
1.6 Summary 
This thesis describes a role for ect-2 in C. elegans ventral enclosure, an event 
that occurs during embryogenesis to cover the embryo in epidermal tissue. Our 
results show that ect-2 likely functions via rho-1 (RhoA) to regulate actomyosin 
contractility, which mediates the migration of ventral epidermal cells. While the 
precise role of ect-2 in their migration is not clear, it likely regulates the formation 
and contractility of an actomyosin supracellular structure that forms around the 
ventral pocket cells and closes via a purse-string mechanism. In addition, we 
found that ect-2 could be part of a genetic pathway that regulates adhesion 
junctions. These results shed light on conserved mechanisms for regulating 








Chapter 2. Materials and methods 
2.1 Strains and alleles 
C. elegans stocks were maintained on NGM plates (1.7% w/v agar, 5 mM 
NaCl, 0.25% w/v Bactopeptone, 1 mM CaCl2, 5 µg/mL cholesterol, 25 mM 
KH2PO4, and 1 mM MgSO4) and fed with E. coli (OP-50) cultured in LB media 
(1% w/v tryptone, 0.5% w/v yeast extract, and 170 mM NaCl) according to 
standard protocol (Brenner, 1974). The following strains were obtained from the 
Caenorhabditis Genetics Center (CGC): N2 (wild-type), ect-2(ax751) II, wsp-
1(gm324) IV, ced-10(n3246) IV, ced-10(n1993)IV, mlc-4(or253)/qC1 dpy-
19(e1259) glp-1 (q339) III,  unc-119(ed3) III; tjls1[pie-1::GFP::rho-1+unc-119(+)], 
ajm-1(ok160) X; jcEx44,  rho-1 (ok2418)/nT1 [qIs51] ), rde-1 (e219), and hmp-
2(qm39) I. The following strains were obtained from colleagues: let-502(sb118) 
from P. Mains (University of Calgary), unc-4(e120); ect-2(zh8) II from A. Hajnal 
(University of Zurich), ect-2(gk44) II; unc-119(ed3) III; xnIs162  [ect-2::GFP + 
unc-119(+)] from J. Nance (Skirball Institute), and nmy-2(cp7[nmy-2::gfp + LoxP 
unc-119(+) LoxP]) I from B. Goldstein (University of North Carolina). The 
following strains were made for this thesis: ect-2(ax751); AJM-1:GFP, ect-
2(ax751); wsp-1(gm324), ect-2(ax751); ced-10(n3246), ect-2(ax751); ced-
10(n1993), ect-2(ax751); rho-1 (ok2418)/+, ect-2(ax751); mlc-4 (or253)/+,  ect-
2(ax751) II; let-502(sb118), NMY-2:GFP; ect-2(ax751), NMY-2:GFP; ect-2(zh8), 
and ect-2(zh8) II; rho-1 (ok2418)/+. All strains maintained at 15oC except GFP 
fluorescent expression strains at 20oC. 
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2.2 Genetic crosses 
Genetic crosses were performed to determine functional requirements for ect-
2. L4/young adult hermaphrodites and L4/young adult male worms were placed 
on NGM plates seeded with E. coli in small circles in the centre of the plate (e.g. 
2-3 cm diameter) to maximize their interactions. Broods were scored from F1 (to 
assess maternal requirement of ect-2), F2 (to assess genetic interactions for 
double mutant combinations using zygotic alleles) or F3 progeny (to assess 
genetic interactions for double mutant combinations using maternal alleles) using 
standard protocols and Chi-square analyses were performed to assess genetic 
interactions (Mains et al., 1990). One modification we adopted was to use eight 
or more L4 stage hermaphrodites, each brooded on two plates with a minimum of 
30 eggs per plate. For crosses using temperature sensitive strains, such as ect-
2(ax751) and let-502(sb118), crosses were performed at 20°C, and the L1’s (let-
502 - zygotic) or L2’s (ect-2 - maternal) were upshifted as L4 stage 
hermaphrodites to 25°C to access lethality of the F2 or F3 generation at 
restrictive temperature. Phenotypes were determined as indicated in the figures 
and tables.     
2.3 Immunostaining 
ECT-2:GFP embryos were fixed and immunostained for GFP in order to 
reveal the expression pattern of ECT-2. First, gravid hermaphrodites were 
treated with a bleach solution (8% bleach and 0.8 M NaOH) to release embryos. 
Then, the embryos were washed three times using equal volumes of M9 solution 
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(3.4 mM Na2HPO4, 2.2 mM KH2PO4, 0.9 mM NaCl, and 0.9 mM NH4Cl). Embryos 
were pipetted onto a poly-lysine coated slide. Next, the embryos were freeze-
cracked by placing coverslips at an angle on the slide (over the embryos) and 
placing the slides in liquid nitrogen for a few seconds, or on dry ice for ~30 sec – 
1 min, then ‘popping’ the coverslips off of the slides. A pap pen was used to draw 
a circle around a central area that had the most embryos. The slides were placed 
in -20°C methanol for 15 minutes, then washed three times for 10 minutes each 
with 0.1% TBST (150 mM NaCl, 50 mM Tris HCl pH 7.6 and 0.1% Tween-20). 
For all of the immunostaining steps, the slides were placed in ‘chambers’, made 
using covered plastic dishes with parafilm and wet paper towels. After washing, 
the embryos were blocked by adding 5% NDS in 0.1% TBST for 30 min at room 
temperature. Then, they were incubated with 1:100 dilution of rabbit anti-GFP 
polyclonal antibodies (gift from Michael Glotzer’s lab, University of Chicago) and 
1:10 mouse MH27 monoclonal antibodies (anti-AJM-1; Developmental Studies 
Hybridoma Bank) in 5% NDS in 0.1% TBST for two hours at room temperature. 
After washing three times with 0.1% TBST, the slides were incubated with 
secondary antibodies (1:250 anti-rabbit antibodies coupled with 488 and1:250 
anti-mouse antibodies coupled with 568; Invitrogen) in 0.1% TBST for two hours 
at room temperature. The slides were then washed three times, and incubated 
for five minutes with 1:1000 DAPI (1 mg/mL; Sigma) in 0.1% TBST, washed once 
with 0.1% TBST, then washed with 0.1M Tris HCl pH 8.8, after which a drop of 
pre-warmed mounting media (5% n-propyl gallate, 50% glycerol, 50 mM Tris pH 
9) was added to each slide and coverslips were added and sealed. Similar 
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procedures were followed to visualize RHO-1 and AJM-1 in GFP:RHO-1 
embryos.  
2.4 Microscopy 
We performed live imaging using DIC or fluorescence microscopy to visualize 
the ect-2 mutant (single or double) phenotypes. Embryos were collected using 
established protocols (Sulston et al., 1983). Gravid (egg-carrying) 
hermaphrodites were transferred to a drop of M9 solution on a depression slide, 
and dissected by a surgical blade to release the embryos. Embryos were then 
added to freshly made 2% agarose pads on slides, using a Pasteur pipette bulb 
coupled to a capillary. Embryos were grouped together using an eyelash glued to 
a toothpick, to form clusters (permits imaging more embryos at once, but it is 
important to have less than 8 embryos clustered to avoid oxygen deprivation). 
Then, coverslips were added to the slides with additional drops of M9 to prevent 
the slides from drying out during imaging, and coverslips were sealed with 
prewarmed liquid Vaseline or VALAP. To observe phenotypes during epidermal 
morphogenesis by Nomarski (DIC), embryos were imaged on the LEICA 
DMI6000B microscope using the 40X objective, and images were captured every 
10 min using a Hamamatsu Orca R2 camera, Piezo Z/ASI stage (MadCityLab), 
and Volocity acquisition software (PerkinElmer). For optimal movies, we captured 
4 Z-planes of 2 µm thickness, every 10 minutes for a total of 7 hours. ect-
2(ax751); AJM-1:GFP and control AJM-1:GFP embryos were imaged with the 
same microscope, but using GFP fluorescence. Time-lapse images were 
acquired with the GFP filter (Semrock), every 12 min using 8 Z-planes of 1 µm 
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thickness from the top to medial planes of the embryo. To prevent embryonic 
lethality caused by phototoxicity, the aperture was closed to 17% to limit light 
intensity, and exposure times were kept below 300 ms. The gain was increased 
to offset the low exposure times, but we kept it below 100 to obtain optimal 
images. To image fixed embryos, images were collected using the same 
microscope, but using the 63X objective, and collecting Z-planes of 0.3 µm 
thickness. Alternatively, the Leica TCS SP2 confocal microscope was used to 
collect images using the 63X objective and Leica confocal software (v1.4), with 
500 ms of exposure, 250 gain, and averaging of two. Images of strains 
expressing AJM-1:GFP, NMY-2:GFP, and ECT-2:GFP were collected using the 
60X objective on an inverted Nikon Eclipse Ti microscope outfitted with the 
Livescan Sweptfield scanner (Nikon), Piezo Z stage (Prior) and the Andor Ixon 
897 camera, with Elements 4.0 acquisition software (Nikon) and the 488 laser 
(set between 10-25% power). Z-stacks of 0.5 μm, for a total distance of 12 µm 
from surface to the middle of embryo, were collected every 10 min. The gain was 
kept below 250, and exposure times were below 300 ms. All imaging was 
performed at room temperature, except a chamber (IBIDI) was used to fix the 
temperature at 25°C on the Leica DMI6000B microscope when imaging single 
and double mutant temperature sensitive allelic combinations. 
 Images were exported into TIFF format to use for post-analysis. Some image 
sets were deconvoluted with AutoQuant 3.1 (Media Cybernetics), while other 
sets were processed with ImageJ (NIH Image) to create Z-stack projections, 
perform image rotation and to crop desired regions. Finally, all images were 
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converted to 8-bit format, then copied and pasted into Illustrator (Adobe) to make 
figures or to generate Quicktime (Apple) movies. 
2.5 Analysis of cell migration and fluorescent intensity 
 Measurements of ventral epidermal cell velocities and myosin intensity 
were performed using Image J. To measure epidermal cell velocity, images 
expressing AJM-1:GFP were used to visualize the boundaries of the epidermal 
cells. Z-stack projections of each time point were generated. Then, using the ‘line 
tool’ function in Image J, the distance from the ‘start’ (using images at earlier time 
points) to the ‘end’ (using images at later time points) of their movement was 
determined in pixels for each ventral epidermal cell pair. Based on the objective 
properties, distance was converted from pixels to µm, and the total distance was 
divided by the total time to give the velocity in µm per min. The velocities for each 
cell pair were averaged together, and collected for mutant and control embryos. 
Standard deviations were calculated, and data was graphed in Excel (Microsoft). 
To measure changes in myosin intensity, the ‘free hand’ selection tool in 
Image J was used to trace regions enriched with NMY-2:GFP signal along the 
margins of the migrating epidermal cells over different time points. After selecting 
the region to be measured, ‘ROI manager’ was used (under the ‘analyze’ section) 
to measure the average intensity and area in pixels. We also measured an ROI 
in other regions of the embryo to create a ratio of ‘relative’ pixel intensity in the 
myosin-enriched regions, vs. other locations in the embryo. This helped control 
for variations in signal intensity due to bleaching, or other slight changes in 
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imaging conditions. The intensity ratios were determined for multiple time points 
during ventral enclosure and compared between the mutant and control 
embryos. Ratios were collected for multiple embryos and averaged together. The 
















Chapter 3. Results 
3.1 ect-2 is maternally required for C. elegans embryogenesis  
The RhoGEF ECT-2 regulates RHO-1 activity to mediate actomyosin 
contractility for cytokinesis in the early embryo, but it is not known if ect-2 
regulates other events during embryogenesis (Dechant and Glotzer, 2003). In C. 
elegans larva, ect-2 regulates epidermal P-cell cytokinesis and migration for 
vulva formation, suggesting that it may regulate actomyosin for events other than 
cytokinesis (Morita et al., 2005). To study ect-2’s functions in later stages of 
embryogenesis, we used ax751, a temperature-sensitive (ts) hypomorphic allele 
of ect-2 that shows few cytokinesis defects at permissive temperatures (Zonies et 
al., 2010). First, we determined the lethality of this allele at various temperatures 
and used DIC imaging to assess phenotypes (Table 1; Figure 6). At permissive 
temperature, ect-2(ax751) displayed moderate lethality, 32% (n = 300), and a 
spectrum of phenotypes across embryogenesis (Table 1). In ect-2(ax751) mutant 
embryos, 16% arrest before the onset of ventral enclosure (Table 1). Another 
37% mutant embryos failed to complete ventral enclosure, and ruptured with their 
internal contents extruding outside of the embryo (Table 1; Figure 6). This 
phenotype is called Gex (gut on the exterior), and was first described in 
Rac/WAVE pathway mutant embryos (Soto et al., 2002). An additional 5% of the 
embryos displayed Vab (variable abnormal body morphology) phenotypes (Table 
1; Figure 6). Vab phenotypes are typically seen in embryos mutant for adhesion 
junction components, where forces that mediate epidermal morphogenesis are 
unevenly distributed across the malformed junctions (Simske et al., 2003). Lastly,  
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N2 20 0 0 0 0 0 
 25 0 -- -- -- -- 
ect-2(ax751) 20 32 16 37 5 15 
 25 95 42 58 0 0 
ect-2(ax751) X 
N2 males 
20 23 -- -- -- -- 
 25 89 -- -- -- -- 
ect-2(zh8) 20 31 8 22 0 0 
ect-2 RNAi 
24hrs 
20 100 100 0 0 0 
 
* The sample size for this column was 130 < n < 300; ect-2(ax751) is the loss-of-function ts allele, 
and ect-2(zh8) is the gain-of-function allele. 
**DIC imaging was performed at room temperature (20-23ºC) for rows indicated as 20ºC, and a 
chamber was used to hold the temperature at 25ºC for rows indicated as 25ºC; 10 < n < 37. Data 








Figure 6. ect-2 is required for ventral enclosure. At the top are DIC time-lapse images of a 
wild-type (N2) embryo from the onset of ventral enclosure to the three-fold stage of elongation. 
Underneath are time-lapse images of ect-2(ax751) (loss-of-function) embryos showing the ventral 
enclosure phenotypes, and the proportion of embryos in each category. The red arrow points to 
the rupture of the embryo, where the internal contents of the embryos extrude. Also shown is an 
ect-2(zh8) (gain-of-function) embryo, which rupture as indicated by the red arrow. All DIC imaging 
was performed at room temperature, and 10<n<30 embryos were imaged. The scale bar is 10um. 









15% of the embryos had delayed ventral enclosure, but embryos continued to 
develop similar to wild type embryos (Table 1; Figure 6). While ventral enclosure 
took less than 50 min to complete in wild-type embryos, it took an average of 90 
min for ect-2 mutant embryos. Consistent with the ts nature of the ax751 allele, 
embryos at restrictive temperature (25oC) had higher embryonic lethality and 
earlier phenotypes in comparison to embryos at permissive temperature (Table 
1). For example, a higher proportion of embryos arrested prior to ventral 
enclosure, and no Vab phenotypes were seen (Table 1). 
We also examined embryonic phenotypes after ect-2 RNAi treatment, and in 
other ect-2 alleles to determine if we could see mid-late embryogenesis 
phenotypes similar to the ax751 allele. Consistent with ect-2’s requirement for 
cytokinesis, ect-2(RNAi) embryos displayed 100% lethality, and appeared to 
have cytokinesis defects (Table 1; data not shown) (Dechant and Glotzer, 2003). 
However, a gain-of-function (gof) allele, zh8, which has excess ECT-2 activity, 
displayed 31% embryonic lethality (n = 156), and the majority of embryos failed 
ventral enclosure and displayed Gex phenotypes (Table 1; Figure 6) 
(Canevascini et al., 2005). The ventral enclosure phenotypes visualized with two 
of the ect-2 alleles support a requirement for ect-2 in C. elegans ventral 
enclosure.           
We also tested if ect-2 is required maternally or zygotically. Ventral enclosure 
occurs during mid-embryogenesis, at the cusp of when many zygotic genes are 
expressed. However, a null allele of ect-2, gk44, is sterile, suggesting that ect-2 
is not required zygotically for embryogenesis. Outcrossing ect-2(ax751) 
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hermaphrodites with wild-type N2 males gave rise to heterozygous ect-
2(ax751)/+ progeny with similar lethality to the homozygous embryos described 
above, suggesting that ect-2 is maternally required for embryogenesis (Table 1).  
 
3.1.1 ect-2 is required for neuroblast migration 
Many genes that are required for ventral enclosure, particularly for 
epidermal cell migration or for adhesion, can display defects in other migratory 
events earlier in embryogenesis (Chin-Sang et al., 1999; Chin-Sang et al., 2002; 
Harrington et al., 2002). For example, after gastrulation, a cleft appears on the 
ventral surface of the embryo and neuroblasts migrate to close this cleft by a 
process called ventral cleft closure (Chisholm and Hardin, 2005). Delays or 
defects in their migration can lead to mis-positioned neuroblasts, which could 
cause ventral enclosure defects, because they act as the substrate for ventral 
epidermal cell migration (Chin-Sang et al., 1999; Chin-Sang et al., 2002). Using 
DIC time-lapse imaging, I measured the time required for ect-2(ax751) mutant 
embryos to develop from the 6-cell stage to the onset of ventral enclosure in 
comparison to control embryos. I observed an average of a 28 min delay 
(p<0.01) in ect-2(ax751) (n=12) mutant embryos compared to control embryos (n 
= 10, Figure 7A), consistent with a requirement for ect-2 in earlier events in 
embryogenesis. 
Since other ventral enclosure genes also regulate ventral cleft closure, I 
determined if ect-2 mutant embryos displayed phenotypes in this process. The 




Figure 7. ect-2 is required for neuroblast migration. (A) The average time for control and ect-2 
mutant embryos to develop from the 6-cell stage to the start of ventral enclosure is shown. ect-
2(ax751) embryos took 28 min longer to reach VE, *p<0.01 by the student t-test. Bars show 
standard deviation. DIC images on the right show embryos at the 6-cell stage, ventral cleft 
closure and onset of ventral enclosure. (B) DIC images show a wild-type embryo going through 
ventral cleft closure, to ventral enclosure and mid-elongation. Underneath is shown a ect-2(ax751) 
embryo with a mis-positioned and persistent ventral cleft (white dashed line). The percentage of 
embryos with ventral cleft closure defects is indicated on the right (n = 15 for wild-type and 





embryos, after which neuroblasts migrated in to close the elongated central cleft 
in less than 20 min (Figure 7B). However, 33% of ect-2 mutant embryos 
displayed persistent or mis-positioned ventral clefts (n = 15, Figure 7B). The 
ventral cleft appeared in random locations on the ventral surface of the embryo, 
and persisted for 50 min or longer in some embryos (Figure 7B). Furthermore, all 
of the ect-2(ax751) mutants with visible, persistent ventral cleft closure defects 
ruptured during later stages of embryogenesis (6/6, Figure 7B). However, not all 
of the ect-2 mutant embryos with ventral enclosure defects displayed ventral cleft 
closure defects, particularly embryos with strong delays. These data suggest ect-
2 is required for multiple events during embryogenesis, including ventral cleft 
closure, and these earlier requirements could contribute to ventral enclosure 
phenotypes. 
3.1.2 ect-2 is required for epidermal cell migration during ventral 
enclosure 
Our previous data supports a role for ect-2 in regulating ventral enclosure. 
We wanted to further analyze this role to determine 1) if ventral epidermal cells 
are properly born and positioned prior to ventral enclosure, and 2) if ventral 
epidermal cells display migratory defects. Particularly since ect-2 is required for 
cytokinesis in the early embryo, it was important to know if the ventral enclosure 
defects in ect-2 mutant embryos could arise (in part) because there are too few 
epidermal cells. To address this, I generated an ect-2(ax751) strain expressing 
AJM-1:GFP to mark the epidermal cell boundaries. Using this strain, I performed 
live imaging at room temperature during mid-embryogenesis, and counted the 
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number of ventral, lateral (seam cell), and dorsal epidermal cells, and took note 
of their relative positions. In all of the ect-2(ax751); AJM-1:GFP mutant embryos 
examined, there was no difference in epidermal cell number or position in 
comparison to control embryos (Table 2). Therefore, the ventral enclosure 
phenotypes in ect-2(ax751) mutant embryos likely are not due to a requirement 
for maternal ect-2 in epidermal cell division.     
Next, we determined if ect-2 is required for ventral epidermal cell 
migration. Together with A. Marte (BIOL 490 student), we performed live imaging 
with the ect-2(ax751); AJM-1:GFP strain to visualize ventral epidermal cell 
migration. In control AJM-1:GFP embryos, we observed a high degree of 
conservation in the movement of ventral epidermal cells, similar to what has 
been previously published (Chisholm and Hardin, 2005). First, two pairs of 
leading cells migrated in and adhered at the ventral midline, followed by the 
migration and closure of posterior-positioned pocket cells at the ventral midline. 
Similar to what I observed using DIC imaging, in control AJM-1:GFP embryos 
ventral enclosure finished within 50 min (n = 15; Figure 8A). In ect-2(ax751); 
AJM-1:GFP embryos, several ventral epidermal cell migration phenotypes were 
observed, consistent with what I found using DIC imaging (Figure 8A). One set of 
mutant embryos displayed migration patterns similar to control embryos, but the 
ventral epidermal cells took more than twice the amount of time to adhere at the 
midline (an average of 110 min, n = 10; Figure 8A). In another subset of ect-2 
mutant embryos, the leading cells failed to reach the midline before the ventral 
pocket attempted to close, and both the  
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Table 2 ect-2 is not required for epidermal cell division. 
 
Genotype Ventral Cell* Dorsal Cell* Seam Cell* 
AJM-1::GFP 11.4 11.9 9.9 
ect-2(ax751); AJM-1:GFP 11.3 11.7 9.8 
 






















Figure 8. ect-2 regulates cell migration during ventral enclosure. (A) The top panel shows a 
control, AJM-1:GFP embryo going through ventral enclosure. Only the ventral epidermal planes 
are shown, and the cells are clearly outlined. The leading cells are marked by a yellow arrow 
head, and migrate and adhere at the ventral midline first, followed by the ventral pocket cells. 
Underneath are shown two different ect-2(ax751) embryos with either delay or rupture 
phenotypes. In both embryos, it takes longer for the VE cells to migrate, and adhere at the 
midline, or in some, they fail to meet altogether. The percentage of phenotypes is shown on the 
right. 9<n<15, and the scale bar is 10 um. (B) A bar graph shows the velocity measurements for 
each ventral epidermal cell pair, as indicated in the embryo above. In control embryos, the first 
two cell pairs (position 1-2) migrate faster compared to the other cells (position 3-9). In ect-
2(ax751) mutant embryos, all cells migrate significantly slower compared to control embryos, 
*p<0.01 by the student t-test, regardless of phenotype (blue = control; delay = light orange; 
ventral open = brown).         
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leading cells and posterior pocket cells remained open (n = 9; Figure 8A). These 
embryos displayed rupture as embryogenesis progressed. 
Next, we measured ventral epidermal cell velocities in control and ect-2 
mutant embryos (Figure 8B). Each cell pair was numbered from 1 (most anterior 
pair) to 9 (most posterior pair; Figure 8B). In control embryos, the 2 most anterior 
leading cell pairs always migrated faster in comparison to the posterior ventral 
pocket cells (above 0.43 μm/min vs. below 0.29 μm/min; Figure 8B) 
(Williams-Masson et al., 1997). However, in ect-2(ax751) embryos, the velocities 
of every cell pair were delayed in comparison to control embryos, regardless of 
the severity of their phenotype (e.g. delay vs. failed migration; Figure 8B). In 
particular, the leading cell pairs were most severely delayed (Figure 8B). For 
example, while the most anterior leading cell pair (position 1) had a velocity of 
0.46 μm/min in control embryos, they only had a velocity of 0.18 μm/min in the 
ect-2 mutant embryos. This data suggests that ect-2 functions to mediate ‘robust’ 
migration of the ventral epidermal cells.      
 
3.1.3 ECT-2 is expressed in neuroblasts and epidermal cells  
Our data supports a role for ect-2 in regulating the migration of 
neuroblasts and ventral epidermal cells. Next, I determined the localization of 
ECT-2 to determine if it is consistent with its biological requirement. Previous 
studies showed that ECT-2 is enriched at the anterior cortex in the early zygote, 
and subsequently localizes around the entire cortex of eight-cell stage embryos 
(Jenkins et al., 2006; Chan and Nance, 2013). Furthermore, ECT-2 is strongly 
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expressed in cells required for gonad/vulva formation (Morita et al., 2005). 
However, the localization of ECT-2 during mid-embryogenesis was not known. 
Recently, Chan and Nance (2013) developed an ECT-2:GFP strain driven by the 
ect-2 promoter and showed that this transgene rescued sterility of null ect-2 
mutant hermaphrodites (gk44) (Chan and Nance, 2013). I crossed this transgene 
to ect-2(ax751) mutant hermaphrodites, to generate a ‘rescued’ homozygous ect-
2(ax751); ECT-2:GFP strain that displays no embryonic lethality (Table 3). The 
ability of the ECT-2:GFP transgene to rescue the ect-2(ax751) phenotypes 
suggests that its localization pattern should accurately depict its biological 
requirements during mid-embryogenesis. I performed immunostaining with fixed 
ECT-2:GFP embryos in ventral enclosure using antibodies to GFP and AJM-1 
(MH27; epidermal junction marker). Images showed that ECT-2 is at the 
boundaries of epidermal cells (Figure 9). However, ECT-2 appeared to be more 
basal in comparison to AJM-1, suggesting that they are in different locations. 
ECT-2 was also clearly visible in the neuroblasts underneath the epidermal cells 
(within 4 μm) (Figure 9). The localization of ECT-2 to epidermal cell boundaries 
supports a role for ect-2 in directly regulating epidermal cell migration. However, 
since ECT-2 is also expressed in neuroblasts, which act as a substrate for the 
migrating ventral epidermal cells, ect-2 could also have a non-autonomous role in 
this process. 
 





Table 3 ECT-2:GFP transgene rescue of ect-2 mutants. 
 
Genotype Phenotype* GFP Expression 
ect-2(gk44) Sterile No 
ect-2(ax751) ~30% embryonic lethality No 
ect-2(gk44); ECT-2:GFP and      
ect-2(ax751); ECT-2:GFP 
<5% embryonic lethality Yes 
 






Figure 9. ECT-2 and RHO-1 localize to epidermal cell boundaries and are in neuroblasts 
during ventral enclosure. ECT-2:GFP (top) or RHO-1:GFP (bottom) embryos were fixed and 
co-stained for GFP and MH27 (AJM-1 to mark epidermal cell boundaries). In both embryos, GFP 
had similar expression patterns at epidermal cell boundaries (in a different location from AJM-1) 
and in the neuroblasts underneath the epidermal cells. The Z planes are 0.3 um and the scale bar 
is 10 um.   
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ECT-2 is the RhoGEF that regulates RhoA activity for cytokinesis in the 
early embryo, and P-cells during larval gonad formation (Dechant and Glotzer, 
2003; Morita et al., 2005). However, in other organisms, Ect2 mediates cell 
migration via regulating Rac activity (van Impel et al., 2009). To determine if rho-
1 is required for ventral enclosure, we examined the localization of RHO-1 and 
determined its genetic requirement during C. elegans mid-embryogenesis. Co-
staining GFP:RHO-1 embryos with antibodies to GFP and AJM-1 (MH27), 
showed that RHO-1 localizes to epidermal cell boundaries and the underlying 
neuroblasts similar to ECT-2 (Figure 9). RHO-1 also localized more basally in 
comparison to AJM-1. Genetic assays also revealed a role for rho-1 in ventral 
enclosure. We imaged embryos containing a zygotic null allele of rho-1, ok2418, 
which produces a truncated product with no activity (Dvorsky and Ahmadian, 
2004). While the majority of homozygous rho-1(ok2418) embryos arrested at the 
2-fold stage of elongation, a small proportion of the embryos displayed lethality at 
earlier developmental stages (Fotopoulos et al., 2013). Embryos treated with 
zygotic-specific rho-1 RNAi phenocopied embryos carrying the ok2418 allele, 
and displayed 59% elongation phenotypes and 41% ventral enclosure 
phenotypes (n = 38, Figure 10A) (Fotopoulos et al., 2013). Imaging rho-
1(ok2418); AJM-1:GFP embryos revealed that these earlier phenotypes were 
consistent with ventral enclosure defects (14%, n = 7). Similar to ect-2(ax751) 
embryos, ventral epidermal cells failed to migrate to the ventral midline, causing 
the embryos to rupture (Figure 10B). These data support a role for rho-1 in 






Figure 10. rho-1 is required for ventral enclosure. (A) The top panel shows DIC images of N2 
embryos going through ventral enclosure and elongation. Underneath is a rho-1 (ok2418) embryo 
with an elongation phenotype. Also shown is a control rde-1 mutant embryo, which displays no 
embryonic phenotypes and resembles the wild-type embryo. Underneath is shown an rde-1 
mutant embryo treated with rho-1 RNAi. These embryos had ventral enclosure phenotypes in 
addition to elongation phenotypes (percentage is shown on the right). (B) Fluorescent images of 
AJM-1:GFP control and rho-1 (ok2418); AJM-1-GFP embryos going through ventral enclosure. 
The percentage of ventral enclosure rupture phenotypes is shown at the right. The scale bar is 10 
um.     
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that ect-2 functions in the rho-1 pathway to mediate ventral epidermal cell 
migration. 
 
3.2 Determine which genetic pathway ect-2 functions in during ventral 
enclosure 
3.2.1 ect-2 likely functions in the Rho pathway 
To determine if ect-2 functions in the rho-1 pathway to mediate ventral 
epidermal cell migration, genetic crosses were performed between ect-2 and 
components of the Rho pathway, including rho-1, let-502 (Rho-binding kinase), 
and mlc-4 (non-myosin regulatory light chain). While the ect-2 allele is not null, 
the rho-1 and mlc-4 alleles are zygotic null, and the let-502 allele is ts with strong 
loss of function phenotypes at restrictive temperature. All of these Rho pathway 
alleles experience defects in late morphogenesis and produce Vab or elongation-
specific phenotypes (grouped as Vab for simplicity) (Shelton et al., 1999; Piekny 
et al., 2000; Dvorsky and Ahmadian, 2004). If ect-2 works as a RhoGEF for the 
Rho pathway, then combining an ect-2 mutant allele with mutations in the 
downstream components should not enhance phenotypes. Our data supports 
this hypothesis, as no or little enhancement of phenotypes was observed 
between ect-2 and Rho pathway components (Table 4). 
Rather, we found that the total phenotypes were less than additive (weak 
suppression), supporting that the genes function within the same pathway. We 
are using hypomorphs or zygotic nulls, and we expect the phenotypes to be 





















N2 20 0 0 0 -- -- -- 
ect-2(ax751) 20 4.6 27.4 32 -- -- -- 
 25 0 90 90 -- -- -- 
ect-2(zh8) 20 0 31 31 -- --  
mlc-4(or253) 
/qC1 
20 23.5 3.6 27.1 -- -- -- 
let-502(sb118) 20 0 9.2 9.2 -- -- -- 
 25 87 13 100 -- -- -- 
rho-1(ok2418)/+ 20 18 7 25 -- -- -- 
ect-2(ax751); 
mlc-4(or253)/+ 
20 10.6 47.4 58 59.1 2 =5.38 




20 5 29 34 41.2 2 =10.8 




 25 50 50 100 >100 N/A N/A 
ect-2(ax751); 
rho-1(ok2418)/+ 
20 5.5 38.5 45 57 2 =8.25 






20 4.4 22.2 26.6 56 2 =29.7 




* Sample size for this column is 100 < n < 400. The percentage of each phenotype were 
determined as the sum of Vab (Variable abnormal body morphology – hatched as deformed 
larva) and embryonic lethal phenotypes. Since none of the alleles are maternal null, the expected 
phenotypes were determined by adding the % of phenotypes for each allele.  
** Significance tested by Chi-squared analysis, 0.05 < p < 0.01 weak effect; p < 0.01 strong 




downstream component. However, we observed shifts in the phenotypes 
depending on the allelic combinations. For example, when combining ect-2 with 
let-502 or mlc-4, we noticed an increase in embryonic lethality at the expense of 
the Vab/elongation-defective phenotypes (Table 4). We also observed an 
increase in the proportion of early phenotypes (before ventral enclosure) in the 
let-502; ect-2 double mutant embryos (Table 5). While we do not know what 
phenotype caused this early lethality, it could be due to their requirement for 
cytokinesis or polarity in the early embryo. 
Imaging ect-2(ax751); let-502(sb118) mutant embryos during mid-late 
embryogenesis revealed interesting phenotypes where embryos had ventral 
enclosure phenotypes, but retained epidermal tissue integrity and were less likely 
to extrude their internal contents (Figure 11, Table 5). The Rho-binding kinase, 
let-502, positively regulates myosin contractility to mediate seam cell shape 
changes for elongation (Piekny and Mains, 2002; Piekny et al., 2005). We found 
that the force generated from the elongating seam cells may put pressure of the 
embryo and cause rupturing when the junctions are not stably formed 
(Fotopoulos et al., 2013). 
We also performed a genetic assay using the gof ect-2 allele and the 
zygotic null rho-1 allele. We predict that since rho-1 is downstream in the 
pathway, increasing ect-2 activity should have no impact on the rho-1 
phenotypes. However, we do not have a maternal allele of rho-1, and the allele 
used in this study is a zygotic null. Since the embryos from heterozygous 
mothers would have wt maternal rho-1, but may have reduced levels vs. wild- 
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Table 5 ect-2 ventral enclosure phenotypes are partially suppressed by let-502. 
Genotype* Before VE% VE Rupture% Vab% Delay% 
N2 0 0 0 0 
ect-2(ax751) 16.1 38.7 6.5 16.1 
let-502(sb118) 4.3 0 95.7 0 
ect-2(ax751); let-502(sb118) 35.3 29.4 35.3 0 
 










Figure 11. ect-2 likely functions in the Rho pathway. The top panel shows DIC images of N2 
embryos going through ventral enclosure and elongation. Underneath is a let-502 mutant embryo, 
which arrests during early-mid elongation. Double let-502; ect-2 mutant embryos display ventral 
enclosure rupture and Vab phenotypes (their proportion is shown on the right). The scale bar is 
10 um.     
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type embryos, we predicted that phenotypes might be alleviated in the double 
mutants. Indeed, we observed suppression of the total number of phenotypes, 
including partial suppression of the rho-1 elongation phenotypes (Table 4). 
Although our preliminary data suggests that ect-2 may work in the Rho pathway 
to regulate ventral enclosure, further studies are required to properly place ect-2 
in the pathway. In particular, imaging AJM-1:GFP in the double mutants with 
weak loss and gain of ect-2 function should reveal if ect-2 works in this pathway 
to mediate ventral epidermal cell migration.  
 
3.2.2 ect-2 may function in parallel with the Rac/Cdc-42 pathway 
In other cell types, Ect2 regulates Rac activity for migration (van Impel et 
al., 2009; Kwiatkowska et al., 2012). Also, previous studies showed that a Rac-
dependent pathway is required for ventral epidermal cell migration during ventral 
enclosure (Sawa et al., 2003; Patel et al., 2008; Bernadskaya et al., 2012). 
Ventral epidermal cells fail to migrate and no longer form actin-rich protrusions in 
embryos with mutations in Rac (CED-10) and its interacting proteins (GEX-2 and 
GEX-3) (Chen et al., 1996; Soto et al., 2002; Patel et al., 2008). Since this is the 
only pathway known to regulate epidermal cell migration, we determined if ect-2 
genetically interacts with Rac or other pathway components (Table 6). To do this, 
we crossed ect-2(ax751) with two different Rac alleles; ced-10(n3246), which 
contains a gain-of-function (gof) mutation, and ced-10(n1993), which contains a 
loss-of-function (lof) mutation (Shakir et al., 2006). We propose that if ect-2 and 















N2 20 0 -- -- -- 
ect-2(ax751) 20 27 -- -- -- 
ced-10(n3246) 20 14 -- -- -- 
ced-10(n1993) 20 6.5 -- -- -- 
wsp-1(gm324) 20 12 -- -- -- 
ect-2(ax751); 
ced-10(n3246) 
20 96 41 2 =269 




20 89 33.5 2 =187 




20 85 39 2 =140 
p < 0.01 
Enhancement 
 
* Sample size is 100 < n < 600; since Vab only exists as a minor phenotype for ect-2 (ax751) and 
was not seen with the other alleles, it was not included in the table. Furthermore, since none of 
the alleles are maternal null, the expected phenotypes were determined by adding the % of 
phenotypes for each allele. 












gof ced-10 allele should suppress ect-2 (or show gof phenotypes), while the lof 
allele may show no change in lethality or enhancement (because neither allele is 
null). Regardless of the ced-10 allele, the double mutants displayed enhanced 
embryonic lethality (Table 6).  
WSP-1/WASP functions downstream of Cdc-42 to regulate Arp2/3 for cell 
migration (Miki et al., 1998; Sawa et al., 2003). We also tested genetic 
interactions between ect-2 and wsp-1 using the gm324 allele, which contains a 
deletion and is a strong lof or null allele (Withee et al., 2004). We observed 
enhanced embryonic lethality with the ect-2(ax751); wsp-1(gm324) double 
mutants compared to the single mutants (Table 6). This data supports that ect-2 
and Rac function in different pathways during embryogenesis. However, imaging 
should be done with the double mutant embryos to assay ventral enclosure-
specific phenotypes, since the enhanced lethality could arise from their roles in 
other embryonic events.       
 
3.3 ect-2 regulates the accumulation of non-muscle myosin during ventral 
enclosure 
3.3.1 Myosin organizes supracellularly during ventral enclosure 
The Rho pathway typically regulates myosin contractility during different 
types of tissue morphogenesis in metazoans (Brock et al., 1996; Roh-Johnson et 
al., 2012). C. elegans ventral enclosure is another type of morphogenetic event, 
and shares some features with dorsal closure in Drosophila, which is known to 
be a myosin-dependent process. Since myosin has not been previously studied 
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in ventral enclosure, we imaged a recently generated NMY-2:GFP strain during 
mid-embryogenesis. This strain was made using the CRISPR system to place 
NMY-2:GFP at the nmy-2 locus, and shows consistently higher expression levels 
compared to a previously made NMY-2:GFP zuls45 strain (Dickinson et al., 
2013). Our imaging studies revealed that myosin foci coalesce into a 
supracellular structure along the margin of the ventral epidermal cells as they 
migrate in toward the ventral midline (Figure 12). At the beginning of ventral 
enclosure, myosin foci are more loosely organized, but as the epidermal cells 
migrate toward the ventral midline, the foci aggregate into a circular structure, 
which becomes a single line as cells adhere at the ventral midline (Figure 12). 
This data shows that nonmuscle myosin is highly organized during ventral 
enclosure, consistent with our findings that rho-1 and ect-2 (key regulators of 
myosin contractility) are required for ventral epidermal cell migration.         
 
3.3.2 ect-2 regulates coalescent of myosin during ventral enclosure 
Next, I determined if ect-2 is required for the enrichment and organization 
of myosin into a ring during ventral enclosure. I generated a strain with ect-
2(ax751); NMY-2:GFP and imaged embryos during development. In mutant 
embryos that displayed strong ventral enclosure phenotypes, there were fewer 
myosin foci, and these foci were not well-organized during ventral enclosure 
(Figure 13A). In mutant embryos that displayed delays in ventral enclosure, the 
myosin foci were less enriched in comparison to control embryos, and the ring 







Figure 12. Non-muscle myosin accumulates as foci along the margins of ventral epidermal 
cells and coalesces into a supracellular structure during ventral enclosure. Live imaging of 
NMY-2:GFP embryos show NMY-2:GFP localization to foci along the margin of ventral epidermal 
cells, which coalesces as cells meet at the ventral midline (n = 9). Underneath are zoomed in 
images of regions highlighting the pattern of accumulation and coalescence (yellow arrows). The 
scale bar is 10 um.      
 


































Figure 13. ect-2 regulates the organization of myosin into supracellular structures during 
ventral enclosure. (A) Images show NMY-2:GFP in control and ect-2 mutant embryos through 
ventral enclosure. The yellow arrow points to NMY-2 accumulation into a supracellular structure. 
The dashed line shows the pattern of foci as they initially coalesce. (B) A graph shows 
measurements of the ratio of average NMY-2 intensity in the coalesced regions (red ROI’s), 
compared to average background intensity (red box). Three time points were measured, as 
indicated by the embryos on the right. Bars show standard deviations. (C) A graph shows the 
total area (in um
2
) of coalesced NMY-2:GFP signal at embryonic stage 2’ (see pictures of 
embryos in B). Bars show standard deviation. The student t-test was used to calculate 
significance, *p<0.01. The scale bar is 10 um.  
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ventral enclosure phenotype had similar myosin distribution patterns as control 
embryos (Figure 13A). I also generated a strain with ect-2 (zh8); NMY-2:GFP to 
determine if increasing ECT-2 activity also affects the organization of myosin 
(Figure 13A). Although some of these embryos ruptured during early ventral 
enclosure, in other embryos I saw that myosin formed into a “V” shape rather 
than the circular “C” shape that was prominent in control embryos (Figure 13A). 
Then, I quantitated the average intensity of NMY-2:GFP at sites of enrichment in 
comparison to background during 3 different time points of ventral enclosure, to 
assess changes in myosin over time (Figure 13B). In control embryos, the ratio of 
NMY-2:GFP was above 2.1 during ventral enclosure; and showed a peak value 
of 2.5, just prior to closure of the ventral pocket cells at the midline (n = 7). In ect-
2(ax751) mutant embryos, the ratio of NMY-2:GFP was below 1.6 in all stages, 
and there was no obvious peak in intensity when ventral pocket cells met at the 
ventral midline (n = 6). In ect-2(zh8) embryos, the ratio of NMY-2:GFP intensity 
was high, similar to control levels, but there was no peak when the ventral pocket 
cells closed (n = 8). Interestingly, although ect-2(zh8) embryos had no extra 
myosin accumulation within the same regions as control embryos, we noticed 
that myosin enrichment occurred over a broader area (Figure 13A). 
Quantification of total area with myosin enrichment from embryos during late 
ventral enclosure, when the supracellular structure was more obvious in control 
embryos, revealed that area with myosin enrichment was increased in ect-2(zh8) 
mutant embryos compared to control embryos (n = 8), and decreased in ect-
2(ax751) embryos (n = 7, Figure 13C). This data supports our previous finding 
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that ect-2 likely works in the Rho pathway to regulate myosin contractility for 
ventral epidermal cell migration.    
 
3.4 ect-2 may regulate adherens junctions 
The formation and stability of adherens junctions is also important for 
successful ventral enclosure. Embryos with mutations in adherens junction 
proteins are unable to form or maintain new junctions, and display ventral 
enclosure phenotypes or are Vab (Costa et al., 1998; Koppen et al., 2001; 
Labouesse, 2006). In mammalian cells, Ect2 regulates adherens junctions 
through a RhoA pathway, and Ect2 depletion causes a decrease in the levels of 
myosin at the junctions, and destabilizes cadherin (Ratheesh et al., 2012). We 
also determined if ect-2 is required for the formation or maintenance of new 
junctions during ventral enclosure. hmp-2 encodes beta-catenin, part of the 
catenin-cadherin complex, and qm39 is a weak lof allele that displays low 
embryonic lethality, and has Vab phenotypes (Figure 14; Tables 7, 8) (Lockwood 
et al., 2008). There was no change in embryonic lethality in ect-2(ax751); hmp-
2(qm39) double mutant embryos compared to the single mutants (Table 7). We 
imaged embryos during development and found that the percentage of ruptured 
embryos during ventral enclosure, and larva with Vab phenotypes was not 
significantly changed in the double mutant compared to the single mutants 
(Figure 14; Table 8). Although more components of the junction should be tested 
to determine if ect-2 is involved in junctions, our data supports that beta-catenin 






Figure 14. ect-2 may regulate adherens junctions. The panels show DIC images of N2 (wild-
type), single mutant ect-2(ax751) and hmp-2(qm39) embryos; and double mutant embryos 
through ventral enclosure and elongation. The proportion of each phenotype is shown on the 



























N2 20 0 -- -- -- 
ect-2(ax751) 20 27.5 -- -- -- 
hmp-2(qm39) 20 1.5 -- -- -- 
ect-2(ax751); hmp-
2(qm39) 
20 33.9 29 2 =1.39 
p > 0.05 
No effect 
 
* Sample size is 200 < n < 300. Expected lethality was determined by adding the proportion of 
phenotypes for each allele, since neither is maternal null. 
** Significance tested by Chi-squared analysis, p > 0.05 indicates no effect.  
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Table 8 ect-2 may be involved in adherens junctions regulation. 
Genotype* Before VE% VE Rupture% Vab% Delay% 
N2 0 0 0 0 
ect-2(ax751) 16.1 37.1 5 14.5 
hmp-2(qm39) 0 7.9 10.5 0 
ect-2(ax751); hmp-2(qm39) 7.4 43.9 19.3 0 
 




However, since neither allele is a null, we have to repeat these studies using 
























Chapter 4. Discussion 
In this thesis we show that ect-2, which encodes a RhoGEF, is required 
for multiple migratory events during C. elegans embryogenesis, including 
neuroblast migration for ventral cleft closure, and epidermal migration for ventral 
enclosure. During ventral cleft closure, neuroblasts migrate to close a depression 
left on the ventral surface of the embryo after gastrulation. During ventral 
enclosure, ventral epidermal cells migrate and adhere at the ventral midline to 
enclose the embryo in a single layer of epidermal cells. Our genetic data 
suggests that ect-2 may regulate myosin contractility to mediate migratory 
events. Moreover, ect-2 may regulate the formation or stability of cell-cell 
junctions during ventral enclosure.  
4.1 ect-2 is required for neuroblast migration 
We found that ect-2 is required for the migration of neuroblasts during ventral 
cleft closure (Figure 7). Neuroblasts serve as a substrate for the migration of 
overlying ventral epidermal cells during ventral enclosure, and mis-positioned 
neuroblasts can cause ventral enclosure defects (Chin-Sang et al., 1999; Chin-
Sang et al., 2002; Ikegami et al., 2012). We found that ECT-2 is enriched in the 
majority of neuroblasts, where it localizes to cell boundaries (Figure 9). 
Furthermore, in ect-2 mutant embryos, we observed persistent and misplaced 
ventral clefts, which resulted in phenotypes in ventral enclosure (Figure 7). These 
data support a role for ect-2 in regulating the migration of neuroblasts. However, 
defects in ventral cleft closure could also arise due to abnormal neuroblast 
division. To determine if ect-2 is required for neuroblast cytokinesis, live imaging 
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will be performed using ect-2 (ax751) mutant embryos co-expressing a 
fluorescent-labeled neuroblast-specific marker, and a second marker for the 
membrane that will allow us to visualize their division in vivo (Fotopoulos et al., 
2013). This experiment will also help us determine if neuroblast cell shape or 
organization is altered in the ect-2 mutant embryos. Since ect-2(ax751) embryos 
have few cytokinesis defects in the early embryo (Zonies et al., 2010), and 
tissues are formed similar to wild-type embryos, we propose that ect-2 mediates 
neuroblast migration vs. their division. 
4.2 ect-2 is required for ventral enclosure 
In addition to regulating neuroblast migration ect-2 is required for ventral 
enclosure during later stages of embryogenesis (Figure 6). ECT-2 localizes to the 
boundaries of epidermal cells in a pattern reminiscent of RHO-1, and is required 
for their migration (Figure 9) (Fotopoulos et al., 2013). Despite the range in 
severity of ventral enclosure phenotypes (e.g. delay vs. rupture) in ect-2 mutant 
embryos, ventral epidermal cells took twice as long to migrate in comparison to 
wild-type cells (Figure 8). In addition, the pattern of cell migration was quite 
different in comparison to wild-type embryos. For example, in some of the ect-2 
mutant embryos, the leading cells met at the same time or even later than the 
ventral pocket cells (Figure 8). This data suggests that ECT-2 mediates the 
migration of ventral epidermal cells by directly regulating their cytoskeletal 
dynamics, or by influencing their dynamics from the underlying neuroblasts. 
There are several ways that ECT-2 could affect migration, either 
autonomously, or non-autonomously. First, the leading cells migrate via actin-rich 
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protrusions that point toward the ventral midline, and ECT-2 could regulate Rac 
or Cdc42 to mediate the formation of these protrusions. Second, the ventral 
pocket cells have actin cables that form at the cell margins to form a ring, and 
ECT-2 could regulate the formation of F-actin for this ring, or the closure of this 
ring via a contractile, purse-string mechanism (Williams-Masson et al., 1997). 
Furthermore, in both leading and pocket cells, ECT-2 could regulate cell shape 
changes that are also required for these cells to migrate. Genetic crosses 
between ect-2(ax751) and components of the rho-1 pathway suggests that they 
function in the same pathway, and we favour a role for ECT-2 in regulating 
actomyosin contractility for ventral enclosure. This role may not be restricted to 
the epidermis, and ECT-2 could also regulate contractility within the neuroblasts 
during ventral enclosure. In Drosophila, the amnioserosa could function similar to 
neuroblasts, since they are required for closure of the epidermis on the dorsal 
surface of the embryo (Jacinto et al., 2002). Interestingly, this tissue has 
extensive actomyosin contractility, which helps organize actomyosin contractility 
in the overlying epidermal cells to mediate effective closure (Kiehart et al., 2000; 
Franke et al., 2005). Therefore, ect-2, in addition to regulating neuroblast 
migration, could also regulate myosin contractility in the neuroblasts to 
coordinate the formation of a supracellular structure that closes the ventral 
pocket.    
Since ect-2 is required for cytokinesis, it is possible that the ventral enclosure 
phenotype in ect-2 mutant embryos is due to an insufficient number of epidermal 
cells. However, there was no difference in the number of epidermal cells in wild-
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type vs. ect-2 mutant embryos, suggesting that ect-2 mediates epidermal cell 
migration without affecting epidermal cytokinesis. The ect-2 mutant allele used in 
this study seems to preferentially give rise to multiple migration defects instead of 
cell division defects. Therefore, we propose that different levels of ECT-2 are 
required to carry out different events (Figure 15). Lowering ECT-2 below a 
threshold could permit ECT-2 to regulate cytokinesis, but not migration, and if 
ECT-2 is drops to even lower levels, then both cytokinesis and migration are 
blocked (Jantsch-Plunger et al., 2000; Loria et al., 2012). 
 
4.3 ect-2 likely functions in the Rho pathway for myosin contractility  
Our data suggests that ect-2 functions in the Rho pathway to regulate cell 
migration. As described earlier, ect-2 similarly functions in the Rho pathway for 
the division and migration of P-cells during later stages of development (Morita et 
al., 2005). We observed ventral enclosure phenotypes in rho-1 mutant embryos, 
and RHO-1 localizes to epidermal cell boundaries with a pattern similar to ECT-2 
(Figures 9). In addition, our genetic studies support that ect-2 could function in 
the Rho pathway (Figures 10, 11; Table 4). Double mutants between ect-2 and 
Rho pathway components showed no enhancement of total phenotypes. We also 
found shifts in phenotypes depending on the allelic combination. For example, 
we saw that some of the rupture phenotypes were suppressed in let-502; ect-2 









Figure 15. Model for the threshold requirements of ect-2 during embryogenesis. For 


















neighboring lateral epidermal cells puts less pressure on the embryo and 
prevents the extrusion of internal contents during later stages of development. 
Interestingly, the double mutant larva had strong Vab phenotypes suggesting that 
ventral enclosure was still defective. We also saw suppression of phenotypes 
between the gof ect-2 allele, and the null rho-1 allele. Although the rho-1 allele 
was not maternal, making it difficult to properly assess a ‘pathway’ with rho-1 or 
ect-2 downstream, the alleviation of ventral enclosure phenotypes coupled with 
the alleviation of elongation phenotypes supports that they could function in the 
same pathway. However, the different phenotypes observed in the double mutant 
combinations need to be better assessed by performing live imaging 
experiments. In particular, using AJM-1:GFP to image the migration rates of the 
ventral epidermal cells will help us determine ‘enhancement’ or ‘suppression’ of 
ventral enclosure phenotypes.   
 Our data also suggests that ect-2 does not function in the Rac/Cdc-42 
pathway to regulate migration. Rac activates the Wave/Scar and Arp2/3 
complexes to promote the nucleation of short, branched actin to form protrusions 
for epidermal cell migration, and mutations in this pathway cause Gex (rupture) 
phenotypes (Patel et al., 2008; Shakir et al., 2008). Double mutants generated 
between ect-2 and Rac pathway components showed enhanced embryonic 
lethality (Table 6). Therefore, ect-2 works in parallel to the Rac pathway to 
regulate ventral enclosure. However, we cannot completely rule out a function for 
ect-2 in the Rac pathway, since all of the alleles we tested were hypomorphs. 
However, ect-2(ax751) displayed enhanced embryonic lethality when combined 
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with a gof Rac allele. We predict that if ECT-2 functions as a GEF for Rac, then 
embryos should display Rac gof phenotypes, regardless of whether or not its 
GEF is functional. However, since ect-2 and Rac could regulate multiple events 
during embryogenesis, the double mutant embryos will have to be analyzed 
specifically during ventral enclosure to properly determine if they are in parallel 
pathways. Since we also have data that supports a role for ect-2 in the Rho 
pathway, we suggest that ect-2 functions in the Rho pathway, and works in 
parallel to the Rac pathway. Rho and Rac typically work antagonistically to 
regulate migration in other cell types; while Rac regulates the formation of short, 
branched F-actin at the front of the cell to form lamellopodia, RhoA regulates the 
formation of stress fibers and generates contractility in the rear of the cell to push 
the cell forward (D'Avino et al., 2004; Shoval and Kalcheim, 2012). In C. elegans, 
Rho and Rac pathways also work antagonistically across different tissues or cell 
types. For example, during embryonic elongation, rho-1 is required to regulate 
myosin contractility within the lateral epidermal cells to mediate their cell shape 
changes, while Rac regulates myosin relaxation in the dorsal and ventral 
epidermal cells (Piekny et al., 2000). Therefore, we favor the hypothesis that ect-
2 works in the Rho pathway to regulate actomyosin events (either in the 
neuroblasts or in the epidermal cells) for ventral enclosure, while the Rac/Cdc-42 
pathway regulates the formation of actin-rich protrusions to mediate ventral 
epidermal cell migration.           




Myosin contractility is required for the migration of many cell types, but it had 
not been shown to have a role in ventral enclosure (Vicente-Manzanares et al., 
2009). Using embryos expressing NMY-2:GFP, we saw the accumulation of 
myosin foci at the margins of migrating ventral epidermal cells in a ring-like 
pattern, which aggregated into a supracellular structure as the cells approached 
the ventral midline (Figure 12). Previous studies showed that thick actin cables 
similarly form along the border of migrating ventral pocket cells. Laser ablation 
caused these cells to immediately retract, suggesting that they were under 
tension (Williams-Masson et al., 1997). Since myosin is the motor protein that 
generates contractile forces, our data is consistent with these earlier studies and 
suggests that a contractile ring forms around the border of the ventral pocket 
cells, which contracts like a purse-string to mediate their closure.  
Our data suggests that ect-2 functions in the Rho pathway, and we predict 
that it regulates myosin activity. Consistent with this prediction, we observed a 
decrease in the intensity of myosin localization in ect-2(ax751) embryos 
expressing NMY-2:GFP. Embryos that had weak, or no ventral enclosure 
phenotypes were similar to control embryos, while embryos that had strong 
delays or rupture phenotypes had low levels of myosin, which failed to form an 
organized supracellular structure. Furthermore, we also saw a mild up-regulation 
of myosin accumulation in embryos with the ect-2 gof allele, and the pattern of 
myosin was different in comparison to control cells (Figure 13). This data 
supports our hypothesis that ect-2 regulates myosin contractility (either in the 
neuroblasts or in the epidermal cells) for ventral enclosure.  
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However, it is not clear how ect-2 affects migration of the leading cells, which 
rely more on their protrusions for migration. In other cell types, myosin 
contractility provides forces that contribute to migration. For example, myosin 
regulates adhesion, as well as the formation and contraction of stress fibers to 
push the cell forward (Giannone et al., 2007; Vicente-Manzanares et al., 2009). 
Myosin could also contribute to the stability and/or retraction of protrusions that 
mediate cell migration. Since ect-2 could regulate myosin, it could influence any 
one of these events to regulate the migration of the leading cells in ventral 
enclosure. We favor the hypothesis that myosin generates forces in either the 
epidermis and/or neuroblasts to coordinate the formation and closure of a 
supracellular contractile ring by a purse-string mechanism.  
4.5 ect-2 may regulate adherens junctions 
Adhesion keeps neighboring cells together during tissue morphogenesis, and 
connects contralateral cell pairs. This is partly mediated by adherens junctions, 
which are regulated by Rho signaling (Chisholm and Hardin, 2005; Vicente-
Manzanares et al., 2009; Martin et al., 2010). C. elegans embryos with mutations 
in adherens junction components have ventral enclosure phenotypes (Costa et 
al., 1998; Koppen et al., 2001). Since Rho regulates adherens junctions in other 
organisms, we performed genetic studies with ect-2(ax751) and adherens 
junctions alleles. We found that embryonic lethality was not enhanced in the 
double mutants, suggesting that they function in the same pathway (Table 7). We 
also found that the double mutant embryos showed similar proportions of ventral 
enclosure phenotypes, further supporting that they function in the same pathway 
69 
 
(Figure 14, Table 8). In mammalian cell-cell junctions, catenins recruit Ect2 and 
locally activate Rho signaling pathway to regulate junction integrity through 
myosin (Ratheesh et al., 2012).  
Based on studies performed in this thesis, we propose a working model for cell 
migration during ventral enclosure, which includes ect-2, myosin, adherens 
junctions, and neuroblasts (Figure 16). In wild-type embryos, well-organized 
neuroblasts provide a substrate for the migration of overlying epidermal cells. 
They could provide chemical and/or mechanical cues that maintain the direction 
and efficiency of their migration. As the actomyosin filaments accumulate at the 
margins of epidermal cells and aggregate into a supracellular ring-like structure, 
the neuroblasts could also contribute to this organization by either providing 
some of their own active myosin filaments, or by forming a template for the ring. 
In all of the ventral epidermal cells, myosin contractility likely regulates the apical 
constriction of these cells and their extension toward the ventral midline. Also, 
adherens junctions formed between neighboring cells keep the cells connected 
so that they migrate as a unit, and connect the contralateral pairs after closure. In 
ect-2 mutants, neuroblasts are not well-organized, making the migration of 
epidermal cells less efficient. In addition, there are lower levels of myosin 
contractility in either the neuroblasts or epidermal cells, which could impede the 







Figure 16. A cartoon model shows how ect-2 regulates ventral enclosure. ect-2 is required 
to stabilize the organization of myosin filaments into an organized supracellular structure around 
the margins of the ventral epidermal cells. The underlying nueroblasts also require ect-2 for their 
proper localization and arrangement to ensure embryogenesis. In addition, it may stabilize the 
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